186 related articles for article (PubMed ID: 12040358)
1. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters.
Läer S; Mir TS; Behn F; Eiselt M; Scholz H; Venzke A; Meibohm B; Weil J
Am Heart J; 2002 May; 143(5):916-22. PubMed ID: 12040358
[TBL] [Abstract][Full Text] [Related]
2. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
3. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
Askari H; Semizel E; Bostan OM; Cil E
Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
Bruns LA; Chrisant MK; Lamour JM; Shaddy RE; Pahl E; Blume ED; Hallowell S; Addonizio LJ; Canter CE
J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure.
Saito M; Kawana J; Ohno T; Hanada K; Kaneko M; Mihara K; Shiomi M; Nagayama M; Sumiyoshi T; Ogata H
Biol Pharm Bull; 2010; 33(8):1378-84. PubMed ID: 20686235
[TBL] [Abstract][Full Text] [Related]
8. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
10. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.
Shaddy RE; Curtin EL; Sower B; Tani LY; Burr J; LaSalle B; Boucek MM; Mahony L; Hsu DT; Pahl E; Burch GH; Schlencker-Herceg R
Am Heart J; 2002 Sep; 144(3):383-9. PubMed ID: 12228773
[TBL] [Abstract][Full Text] [Related]
11. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
13. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
15. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
[TBL] [Abstract][Full Text] [Related]
16. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.
Albers S; Meibohm B; Mir TS; Läer S
Br J Clin Pharmacol; 2008 Apr; 65(4):511-22. PubMed ID: 17995971
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis].
Li R; Yi QJ; Qian YR; Liu XY; Zhong JR; Bai YH; Mi Q; Li XL
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):684-7. PubMed ID: 19099859
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
Yildirir A; Sade E; Tokgozoglu L; Oto A
Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
[TBL] [Abstract][Full Text] [Related]
20. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
